Browsing by Author Chiew, Yoke-Eng

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2008Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerBalleine, Rosemary; Chiew, Yoke-Eng; deFazio, Anna; Guminski, Alexander; Harnett, Paul; Kennedy, Catherine Jane; Lei, Ying; Pryor, Kylie; Rizos, Helen; Scurr, Lyndee; Brand, Alison; Byth, Karen; Sharma, Raghwa; Wain, Gerard V.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer, Clinical Cancer Research, vol.14, 21, 2008,pp 6924-6932
2017EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomasdeFazio, Anna; Harnett, Paul; Lei, Ying; Moujaber, T; Sharma, Raghwa; Azar, Walid; Chiew, Yoke-Eng; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Garsed, Dale; Hendley, Joy; Kennedy, Catherine; Li, Jason; Mitchell, Chris; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Medicine; Medicine; Medicine; Westmead Clinical School: PathologyEIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas, Cancer Research, vol.77, 16, 2017,pp 4268-4278
2015Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association ConsortiumChiew, Yoke-Eng; deFazio, Anna; Gao, Bo-Fu; Kennedy, Catherine Jane; Beckmann, M W; Beesley, Jonathan; Ekici, Arif B; et al, Various; Fasching, Peter A.; Hein, Alexander; Johnatty, Sharon E.; Kar, Siddhartha; Lambrechts, Diether; Lu, Yi; Tyrer, Johnathan; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium, Clinical Cancer Research, vol.21, 23, 2015,pp 5264-5276
2014Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverBalleine, Rosemary; Brand, Alison; Clarke, Christine; deFazio, Anna; Emmanuel, Catherine; Harnett, Paul; Hogg, Russell; Kennedy, Catherine Jane; Sharma, Raghwa; Wain, Gerard; Anglesio, Michael S.; Chiew, Yoke-Eng; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Galletta, Laura; George, Joshy; Hung, Jillian A.; MacConaill, Laura; Palescandolo, Emanuele; Russell, P; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Pathology; Western Clinical School: Obstetrics & GynaecologyGenomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver, Clinical Cancer Research, vol.20, 24, 2014,pp 6618-6630
2017Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerChiew, Yoke-Eng; deFazio, Anna; Hung, Jillian; Kennedy, Catherine Jane; Chornokur, G; Dennis, J.S.; et al, Various; Karr, S; Kuchenbaecker, Karoline; Lawrenson, Kate; Phelan, C; Pirie, Ailith; Riggan, M; Tyrer, Johnathan; Winham, Stacey J.; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Obstetrics & GynaecologyIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer, Nature Genetics, vol.49, 5, 2017,pp 680-691
2015Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesChiew, Yoke-Eng; deFazio, Anna; Sharma, Raghwa; Anglesio, Michael; Doyle, Maria; et al, Various; Gilks, B; Hunter, Sally M; Li, Jason; Moss, Philip; Rowley, Simone; Ryland, Georgina; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: PathologyMolecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes, Oncotarget, vol.6, 35, 2015,pp 37663-37677
2008Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.deFazio, Anna; Australian Ovarian Cancer Study Group, (AOCSG); Bowtell, David D L; Brown, Robert; Chiew, Yoke-Eng; Etemadmoghadam, Dariush; Fereday, Sian; Fox, Stephen B.; George, Joshy; Gertig, Dorota; Haviv, Izhak; Hung, Jillian A.; Johnson,, Daryl S.; Lade, Stephen; Locandro, Bianca; Tinker, Anna V.; Tothill, Richard W.; Traficante, Nadia; Trivett, Melanie K.; Western Clinical School: Westmead Millennium InstituteNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome., Clinical Cancer Research, vol.14, 16, 2008,pp 5198-5208
2005Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.Balleine, Rosemary; Byrne, Jennifer; Byth Wilson, Karen; Chiew, Yoke-Eng; deFazio, Anna; Harnett, Paul; Livnat, Y; Peters, Gregory; Fejzo, Marlena Schoenberg; Karlan, Beth Y; Mercieca, Janelle; Slamon, Dennis J; St.Heaps, Luke; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Paediatrics & Child Health; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Paediatrics & Child HealthTumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer., International Journal of Cancer, vol.117,(6),2005,pp 1049-54
2015Whole-genome characterization of chemoresistant ovarian cancerChiew, Yoke-Eng; deFazio, Anna; Harnett, Paul; Hung, Jillian; Kennedy, Catherine Jane; McNally, Orla; Alsop, Kathryn; Bailey, Peter; Christie, Elizabeth; Cowin, Prue; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Garsed, Dale; George, Joshy; Nones, Katia; Patch, Anne-Marie; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteWhole-genome characterization of chemoresistant ovarian cancer, Nature, vol.521, 7553, 2015,pp 489-494